Evidence map›Paper›PMID 26260899›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2016

Neurocognitive impairment in the deficit subtype of schizophrenia.

Gagan Fervaha, Ofer Agid, George Foussias, Ishraq Siddiqui, Hiroyoshi Takeuchi, Gary Remington

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Polygenic Risk Scores for Subtyping of Schizophrenia.Schizophrenia research and treatment · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gagan FervahaSchizophrenia Division and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Room 320, Toronto, ON, M5T 1R8, Canada. gagan.fervaha@utoronto.ca.
Ofer AgidSchizophrenia Division and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Room 320, Toronto, ON, M5T 1R8, Canada.
George FoussiasSchizophrenia Division and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Room 320, Toronto, ON, M5T 1R8, Canada.
Ishraq SiddiquiSchizophrenia Division and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Room 320, Toronto, ON, M5T 1R8, Canada.
Hiroyoshi TakeuchiSchizophrenia Division and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Room 320, Toronto, ON, M5T 1R8, Canada.
Gary RemingtonSchizophrenia Division and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Room 320, Toronto, ON, M5T 1R8, Canada.
Centre for Addiction and Mental Health · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia is a heterogeneous disorder characterized by numerous diverse signs and symptoms. Individuals with prominent, persistent, and idiopathic negative symptoms are thought to encompass a distinct subtype of schizophrenia. Previous work, including studies involving neuropsychological evaluations, has supported this position. The present study sought to further examine whether deficit patients are cognitively distinct from non-deficit patients with schizophrenia. A comprehensive neurocognitive battery including tests of verbal memory, vigilance, processing speed, reasoning, and working memory was administered to 657 patients with schizophrenia. Of these, 144 (22 %) patients were classified as deficit patients using a proxy identification method based on severity, persistence over time, and possible secondary sources (e.g., depression) of negative symptoms. Deficit patients with schizophrenia performed worse on all tests of cognition relative to non-deficit patients. These patients were characterized by a generalized cognitive impairment on the order of about 0.4 standard deviations below that of non-deficit patients. However, when comparing deficit patients to non-deficit patients who also present with negative symptoms, albeit not enduring or primary, no group differences in cognitive performance were found. Furthermore, a discriminant function analysis classifying patients into deficit/non-deficit groups based on cognitive scores demonstrated only 62.3 % accuracy, meaning over one-third of individuals were misclassified. The deficit subtype of schizophrenia is not markedly distinct from non-deficit schizophrenia in terms of neurocognitive performance. While deficit patients tend to have poorer performance on cognitive tests, the magnitude of this effect is relatively modest, translating to over 70 % overlap in scores between groups.

Indexed as

Schizophrenic PsychologyAdultCognition DisordersFemaleHumansMaleMiddle AgedNeuropsychological TestsSchizophreniaStatistics, NonparametricAmotivationAvolition–apathyDeficit syndromeNeurocognitionPersistent negative symptomsPsychotic disorder

Identifiers

PMID26260899
OpenAlexW1145171187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.